Daniel Shouval

Research interests

Publications

• EASL position paper on the use of COVID-19 vaccines in patients with chronic liver diseases, hepatobiliary cancer and liver transplant recipients

  Journal of Hepatology · 2021 · https://doi.org/10.1016/j.jhep.2021.01.032

• Type A viral hepatitis: A summary and update on the molecular virology, epidemiology, pathogenesis and prevention

  Journal of Hepatology · 2017 · https://doi.org/10.1016/j.jhep.2017.08.034

• Immunosuppression and HBV Reactivation

  Seminars in Liver Disease · 2013 · https://doi.org/10.1055/s-0033-1345722

• Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1012912

• Telaprevir for Retreatment of HCV Infection

  New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1013086

• Statements from the Taormina expert meeting on occult hepatitis B virus infection

  Journal of Hepatology · 2008 · https://doi.org/10.1016/j.jhep.2008.07.014

• The global impact of vaccination against hepatitis B: A historical overview

  Vaccine · 2008 · https://doi.org/10.1016/j.vaccine.2008.09.056

• Screening, prevention and treatment of viral hepatitis B reactivation in patients with haematological malignancies

  British Journal of Haematology · 2007 · https://doi.org/10.1111/j.1365-2141.2006.06465.x

• Acute Hepatitis A Infection in Pregnancy Is Associated With High Rates of Gestational Complications and Preterm Labor

  Gastroenterology · 2006 · https://doi.org/10.1053/j.gastro.2006.01.007

• Entecavir versus Lamivudine for Patients with HBeAg-Negative Chronic Hepatitis B

  New England Journal of Medicine · 2006 · https://doi.org/10.1056/nejmoa051287

• Hepatitis B vaccines

  Journal of Hepatology · 2003 · https://doi.org/10.1016/s0168-8278(03)00152-1

• Hepatitis A booster vaccination: is there a need?

  The Lancet · 2003 · https://doi.org/10.1016/s0140-6736(03)14418-2

• Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers

  Blood · 2002 · https://doi.org/10.1182/blood.v100.2.391

• Hepatitis B Immune Globulin to Prevent Hepatitis B Virus Graft Reinfection Following Liver Transplantation: A Concise Review

  Hepatology · 2000 · https://doi.org/10.1053/jhep.2000.19789

• A Controlled Trial of a Formalin-Inactivated Hepatitis A Vaccine in Healthy Children

  New England Journal of Medicine · 1992 · https://doi.org/10.1056/nejm199208133270702

• Relapsing Hepatitis A Review of 14 Cases and Literature Survey

  Medicine · 1992 · https://doi.org/10.1097/00005792-199201000-00002

• p53 mutation in hepatocellular carcinoma after aflatoxin exposure

  The Lancet · 1991 · https://doi.org/10.1016/0140-6736(91)92236-u

• Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular Carcinoma

  New England Journal of Medicine · 1981 · https://doi.org/10.1056/nejm198110293051807

• Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line

  Nature · 1980 · https://doi.org/10.1038/286531a0

Current projects

No projects listed.